Publications by authors named "Wigyon Shin"

Claim this Profile
A
A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with mutations.
Takeshi Yamaura, Toshiyuki Nakatani, Ken Uda, Hayato Ogura, Wigyon Shin, Shinji Hagiwara

Bloodยท January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis